FDA Clearance Tracker · P230012
UNIPURE SF6 Ophthalmic Gas in the UNIFEYE Gas Delivery System, UNIPURE SF6 Ophthalmic Gas in the UNIPEXY Gas Delivery Sy
Last checked: Nov 20, 2026Latest source record: Aug 26, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Aug 26, 2024
Approved
Time to decision
524 days
Received Mar 21, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P230012
- Device name
- UNIPURE SF6 Ophthalmic Gas in the UNIFEYE Gas Delivery System, UNIPURE SF6 Ophthalmic Gas in the UNIPEXY Gas Delivery Sy
- Applicant
- Alcon Research, LLC
- Applicant location
- Lake Forest, CA
- Received
- Mar 21, 2023
- Decided
- Aug 26, 2024
- Decision
- Approved
- Supplements
- 11 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Regulation
- 21 CFR 886.4270
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for UNIPURE SF6 Ophthalmic Gas in the UNIFEYE Gas Delivery System and UNIPURE SF6 Ophthalmic Gas in the UNIPEXY Gas Delivery System. The UNIPURE SF6 Ophthalmic Gas in the UNIFEYE Gas Delivery System is indicated for intraocular injection into the eye for the treatment of uncomplicated retinal detachments. Associated measures used include vitrectomy, fluid/air exchange, transconjunctival and transscleral cryotherapy, laser photocoagulation, and air/gas exchange.The UNIPURE SF6 Ophthalmic Gas in the UNIPEXY Gas Delivery System is indicated for intraocular injection into the eye for the treatment of uncomplicated retinal detachments. Associated measures used include vitrectomy, fluid/air exchange, transconjunctival and transscleral cryotherapy, and laser photocoagulation.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LPO. The earliest in FDA's data is P900066, decided Feb 25, 1993.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Alcon Research, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P220030 · Decided Jul 2, 2024 · 564 days after receipt
Device type: Gases used within eye to place pressure on detached retina (LPO) · Ophthalmology
- LEGION System510(k)
K191650 · Decided Nov 1, 2019 · 134 days after receipt
Device type: Unit, Phacofragmentation (HQC) · Ophthalmology
P170034 · Decided Aug 10, 2018 · 284 days after receipt
Device type: Intraocular pressure lowering implant (OGO) · Ophthalmology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.